Cited by 2,593Cancer survivorship and careMobile Health and mHealth ApplicationsPain Management and Opioid Use

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

Open access

Basch, Ethan, Deal, Allison M., Kris, Mark G., Scher, Howard I., Hudis, Clifford A., Sabbatini, Paul, Rogak, Lauren, Bennett, Antonia V., Dueck, Amylou C., Atkinson, Thomas M., Chou, Joanne F., Dulko, Dorothy, Sit, Laura, Barz, Allison, Novotny, Paul, Fruscione, Michael, Sloan, Jeff A., Schrag, Deborah·2016·Journal of Clinical Oncology

DOI 10.1200/jco.2015.63.0830PMC PMC4872028

Open this paper in CoChat — free account

Abstract

Purpose: There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited. Methods: We randomly assigned patients receiving routine outpatient chemotherapy for advanced solid tumors at Memorial Sloan Kettering Cancer Center to report 12 common symptoms via tablet computers or to receive usual care consisting of symptom monitoring at the discretion of clinicians. Those with home computers received weekly e-mail prompts to report between visits. Treating physicians received symptom printouts at visits, and nurses received e-mail alerts when participants reported severe or worsening symptoms. The primary outcome was change in health-related quality of life (HRQL) at 6 months compared with baseline, measured by the EuroQol EQ-5D Index. Secondary endpoints included emergency room (ER) visits, hospitalizations, and survival. Results: Among 766 patients allocated, HRQL improved among more participants in the intervention group than usual care (34% v 18%) and worsened among fewer (38% v 53%; P < .001). Overall, mean HRQL declined by less in the intervention group than usual care (1.4- v 7.1-point drop; P < .001). Patients receiving intervention were less frequently admitted to the ER (34% v 41%; P = .02) or hospitalized (45% v 49%; P = .08) and remained on chemotherapy longer (mean, 8.2 v 6.3 months; P = .002). Although 75% of the intervention group was alive at 1 year, 69% with usual care survived the year (P = .05), with differences also seen in quality-adjusted survival (mean of 8.7 v. 8.0 months; P = .004). Benefits were greater for participants lacking prior computer experience. Most patients receiving intervention (63%) reported severe symptoms during the study. Nurses frequently initiated clinical actions in response to e-mail alerts. Conclusion: Clinical benefits were associated with symptom self-reporting during cancer care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1200/jco.2015.63.0830

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,957
Measuring Quality of Life in Routine Oncology Practice Improves Communication and Patient Well-Being: A Randomized Controlled Trial
Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.078 · Cited by 1,382
Health-Related Quality-of-Life Assessments and Patient-Physician Communication: A Randomized Controlled Trial
Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002) · JAMA · doi:10.1001/jama.288.23.3027 · Cited by 1,011
What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled Trials
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Domenico, D. D., Croy, S., & MacGillivray, S. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 953
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard, A. S., Neary, M. P., & Cella, D. F. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-70 · Cited by 932
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations
Snyder, C., Aaronson, N., Choucair, A., Elliott, T. E., Greenhalgh, J., Halyard, M., Hess, R., Miller, D. M., Reeve, B., & Santana, M. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0054-x · Cited by 808
A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting
Chen, J., Ou, L., & Hollis, S. J. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-211 · Cited by 796
The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature
Valderas, J. M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C. E., Halyard, M. Y., Revicki, D. A., Symonds, T., Parada, A., & Alonso, J. (2008) · Quality of Life Research · doi:10.1007/s11136-007-9295-0 · Cited by 775
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Basch, E., Jia, X., Heller, G., Leahy, A. B., Sit, L., Fruscione, M., Appawu, M., Iasonos, A. E., Atkinson, T. M., Goldfarb, S. B., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp386 · Cited by 622
Self-citation

Flagged first, then by citations

Show all 36 references

Sorted by citations

Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017) · JAMA · doi:10.1001/jama.2017.7156 · Cited by 2,302
Self-citation
Epithelial ovarian cancer
Lheureux, S., Gourley, C., Vergote, I. B., & Oza, A. M. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32552-2 · Cited by 2,017
Integration of oncology and palliative care: a Lancet Oncology Commission
Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E. D., Brunelli, C., Caraceni, A. T., Cervantes, A. M. R., Currow, D. C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30415-7 · Cited by 879
Bladder cancer
Şanlı, Ö., Dobruch, J. T., Knowles, M. A., Burger, M., Mehrdad Alemozaffar, A., Nielsen, M. E., & Lotan, Y. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.22 · Cited by 825
Management of Cancer Cachexia: ASCO Guideline
Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E. D., Fabbro, E. D., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00611 · Cited by 691
Patient-Reported Outcomes — Harnessing Patients’ Voices to Improve Clinical Care
Basch, E. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1611252 · Cited by 637
Self-citation
Patient-clinician communication: American Society of Clinical Oncology consensus guideline
Gilligan, T., Coyle, N., Frankel, R. M., Berry, D. L., Bohlke, K., Epstein, R. M., Finlay, E., Jackson, V. A., Lathan, C. S., Loprinzi, C. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.2311 · Cited by 610
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Burstein, H. J., Krilov, L., Aragon‐Ching, J. B., Baxter, N. N., Chiorean, E. G., Chow, W. A., Groot, J. F. D., Devine, S. M., DuBois, S. G., El‐Deiry, W. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.5292 · Cited by 603
How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis
Greenhalgh, J., Gooding, K., Gibbons, E. J., Dalkin, S. M., Wright, J. M., Valderas, J. M., & Black, N. A. (2018) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-018-0061-6 · Cited by 597
“An RCT published subsequent to the systematic review showed a similar pattern, revealing that feedback of patient reported symptoms and side effects resulted in reduced symptom severity, improved health related quality of life (as measured by the EQ-5D), receipt of active chemotherapy for longer, reduced visits to the…”
Method
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline
Di Maio, M., Basch, E., Denis, F., Fallowfield, L. J., Ganz, P. A., Howell, D., Kowalski, C., Perrone, F., Stover, A. M., Sundaresan, P., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.04.007 · Cited by 509
Self-citation
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients
Denis, F., Lethrosne, C., Pourel, N., Molinier, O., Pointreau, Y., Domont, J., Bourgeois, H., Senellart, H., Trémolières, P., Lizée, T., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx029 · Cited by 482
“noted an increase from 6% to 14% in the survival of 766 patients receiving chemotherapy whose symptoms were monitored via tablet computer (4).”
Background
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Grossberg, A. J., Chu, L. C. H., Deig, C. R., Fishman, E. K., Hwang, W. L., Maitra, A., Marks, D. L., Mehta, A., Nabavizadeh, N., Simeone, D. M., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21626 · Cited by 500
Improving patient and caregiver outcomes in oncology: Team‐based, timely, and targeted palliative care
Hui, D., Hannon, B. L., Zimmermann, C., & Bruera, E. D. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21490 · Cited by 443
Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial
Basch, E., Schrag, D., Henson, S., Jansen, J., Ginos, B., Stover, A. M., Carr, P., Spears, P. A., Jonsson, M., Deal, A. M., et al. (2022) · JAMA · doi:10.1001/jama.2022.9265 · Cited by 413
Self-citation
Implementation of Patient-Reported Outcomes in Routine Medical Care
Basch, E., Barbera, L. C., Kerrigan, C. L., & Velikova, G. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200383 · Cited by 415
Self-citation
Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis
Gaertner, J., Siemens, W., Meerpohl, J. J., Antes, G., Meffert, C., Xander, C. J., Stock, S., Müeller, D., Schwarzer, G., & Becker, G. (2017) · BMJ · doi:10.1136/bmj.j2925 · Cited by 396
Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue
Henson, L. A., Maddocks, M. M., Evans, C., Davidson, M., Hicks, S., & Higginson, I. J. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.00470 · Cited by 381
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology–RTOG 1203
Klopp, A. H., Yeung, A. R., Deshmukh, S., Gil, K. M., Wenzel, L. B., Westin, S. N., Gifford, K. A., Gaffney, D. K., Small, W. C., Thompson, S., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.4273 · Cited by 368
“assessed with patient-reported measures of toxicity during chemotherapy, clinical incorporation of PROs improved healthrelated QOL and increased the number of cycles of chemotherapy received.(19) Given the sensitivity of PROs at detecting clinically significant toxicity during pelvic RT and the potential for medical a…”
Method
Optimal pain management for patients with cancer in the modern era
Scarborough, B. M., & Smith, C. B. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21453 · Cited by 367
“Inversely, increased symptom monitoring and patient self-reporting of pain has been shown to improve HRQOL, decrease unexpected health care utilization, and improve adherence to antineoplastic treatment.(7) Despite understanding the influence of pain on clinical outcomes, pain is often undertreated in patients with ca…”
Background
A review of the barriers to using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine cancer care
Nguyen, H., Butow, P., Dhillon, H., & Sundaresan, P. (2021) · Journal of Medical Radiation Sciences · doi:10.1002/jmrs.421 · Cited by 351
“2 vs 25 months respectively).(19,20) Capturing population-level PRO data systematically over time can also improve the safety and quality of healthcare delivery.”
Background
Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies
Lentz, R. W., Benson, A. B., & Kircher, S. M. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25374 · Cited by 338
Maximising the impact of patient reported outcome assessment for patients and society
Calvert, M., Kyte, D., Price, G., Valderas, J. M., & Hjollund, N. H. (2019) · BMJ · doi:10.1136/bmj.k5267 · Cited by 328
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy
Absolom, K., Warrington, L., Hudson, E., Hewison, J., Morris, C., Holch, P., Carter, R., Gibson, A., Holmes, M., Clayton, B., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02015 · Cited by 311
Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches
Guo, C., Ashrafian, H., Ghafur, S., Fontana, G., Gardner, C., & Prime, M. S. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00314-2 · Cited by 345
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
Aapro, M., Bossi, P., Dasari, A. N., Fallowfield, L. J., Gascón, P., Geller, M. A., Jordan, K., Kim, J. W., Martin, K., & Porzig, S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05539-1 · Cited by 335
Clinical trial design in the era of precision medicine
Fountzilas, E., Tsimberidou, A. M., Vo, H. H., & Kurzrock, R. (2022) · Genome Medicine · doi:10.1186/s13073-022-01102-1 · Cited by 332
“The use of PROMs in patients with cancer has been correlated with improved clinical outcomes, including symptom control [86, 156], better quality of life [86, 157], decreased emergency department visits/hospitalizations [158], and longer survival [158–161].”
Background
Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings
Stover, A. M., Haverman, L., van Oers, H. A., Greenhalgh, J., Potter, C., Ahmed, S., Greenhalgh, J., Gibbons, E. J., Haverman, L., Manalili, K., et al. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02564-9 · Cited by 313
Communication With Older Patients With Cancer Using Geriatric Assessment
Mohile, S. G., Epstein, R. M., Hurria, A., Heckler, C. E., Canin, B. E., Culakova, E., Duberstein, P. R., Gilmore, N. J., Xu, H., Plumb, S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.4728 · Cited by 302
Patient-reported outcome use in oncology: a systematic review of the impact on patient-clinician communication
Yang, L. Y., Manhas, D. S., Howard, A. F., & Olson, R. A. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3865-7 · Cited by 270
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)
Maguire, R., McCann, L., Kotronoulas, G., Kearney, N., Ream, E., Armes, J., Patiraki, E., Furlong, E., Fox, P., Gaiger, A., et al. (2021) · BMJ · doi:10.1136/bmj.n1647 · Cited by 243
Nausea and vomiting of pregnancy and hyperemesis gravidarum
Fejzo, M. S., Trovik, J., Grooten, I. J., Sridharan, K., Roseboom, T. J., Vikanes, Å., Painter, R. C., & Mullin, P. M. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0110-3 · Cited by 306
The increasing value of eHealth in the delivery of patient-centred cancer care
Penedo, F. J., Oswald, L. B., Kronenfeld, J. P., Garcia, S. F., Cella, D., & Yanez, B. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30021-8 · Cited by 252
The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the “Real-World”: Results from the Population-Based PROFILES Registry
Husson, O., de Rooij, B. H., Kieffer, J. M., Oerlemans, S., Mols, F., Aaronson, N. K., van der Graaf, W. T. A., & van de Poll-Franse, L. V. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0348 · Cited by 251
Patient-reported outcomes in cancer care — hearing the patient voice at greater volume
LeBlanc, T. W., & Abernethy, A. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.153 · Cited by 254
A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer
Ong, W. L., Schouwenburg, M. G., van Bommel, A. C. M., Stowell, C. J., Allison, K. H., Benn, K., Browne, J. P., Cooter, R. D., Delaney, G. P., Duhoux, F. P., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4851 · Cited by 246
S3-Leitlinie – Kolorektales Karzinom
Schmiegel, W., Buchberger, B., Follmann, M., Graeven, U., Heinemann, V., Langer, T. G., Nothacker, M., Porschen, R., Rödel, C. M., Rösch, T., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-121106 · Cited by 247
Patient reported outcome measures in rare diseases: a narrative review
Slade, A. L., Isa, F., Kyte, D. G., Pankhurst, T., Kerecuk, L., Ferguson, J., Lipkin, G. W., & Calvert, M. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0810-x · Cited by 258
Health-Related Quality of Life
Sitlinger, A. P., & Zafar, S. Y. (2018) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2018.05.008 · Cited by 248
The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer
Nipp, R. D., El‐Jawahri, A., Moran, S. M., D'Arpino, S. M., Johnson, P. C., Lage, D. E., Wong, R. L., Pirl, W. F., Traeger, L., Lennes, I. T., et al. (2017) · Cancer · doi:10.1002/cncr.30912 · Cited by 230
“patient-reported outcomes into routine processes of care are promising strategies to reduce symptom burden and enhance patient-reported outcomes.(38,39) Future research should also focus on testing the potential efficacy of such interventions on reducing patients’ use of health care services.”
Background
Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review
Lisy, K., Langdon, L., Piper, A., & Jefford, M. (2019) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13176 · Cited by 215
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial
Reck, M., Schenker, M., Lee, K. H., Provencio, M., Nishio, M., Leśniewski-Kmak, K., Sangha, R. S., Ahmed, S. I., Raimbourg, J., Feeney, K., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.05.008 · Cited by 220
Automated home monitoring and management of patient‐reported symptoms during chemotherapy: results of the symptom care at home RCT
Mooney, K. H., Beck, S. L., Wong, B. G., Dunson, W., Wujcik, D. M., Whisenant, M., & Donaldson, G. W. (2017) · Cancer Medicine · doi:10.1002/cam4.1002 · Cited by 210
Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice
Sidey-Gibbons, C. J., Porter, I. H., Gonçalves, D. C., Stoilov, S., Ricci‐Cabello, I., Tsangaris, E., Gangannagaripalli, J., Davey, A. F., Gibbons, E. J., Kotzeva, A., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011589.pub2 · Cited by 220
Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial
Basch, E., Stover, A. M., Schrag, D., Chung, A., Jansen, J., Henson, S., Carr, P., Ginos, B., Deal, A., Spears, P. A., et al. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00081 · Cited by 194
“A prior large, real-world single-center randomized controlled trial demonstrated that such an ePRO system (the “STAR” system) improved patients’ symptom control and quality of life, decreased emergency room visits, lengthened time tolerating chemotherapy, and increased overall survival.(12,13) To evaluate a digital eP…”
BackgroundSelf-citation
Timely Palliative Care: Personalizing the Process of Referral
Hui, D., Heung, Y. J., & Bruera, E. D. (2022) · Cancers · doi:10.3390/cancers14041047 · Cited by 215
Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada
Kluetz, P. G., O’Connor, D. J., & Soltys, K. M. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30097-4 · Cited by 199
Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review
Graupner, C., Kimman, M., Mul, S., Slok, A. H. M., Claessens, D., Kleijnen, J., Dirksen, C. D., & Breukink, S. O. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05695-4 · Cited by 195
Development and validation of an interpretive guide for PROMIS scores
Rothrock, N. E., Amtmann, D., & Cook, K. F. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-0181-7 · Cited by 194
Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review
Warrington, L., Absolom, K. L., Conner, M. T., Kellar, I., Clayton, B., Ayres, M., & Velikova, G. (2018) · Journal of Medical Internet Research · doi:10.2196/10875 · Cited by 200
“For trials described in the section on patient-centered outcomes [5,6,8,49,60,79,88,100], the median score was higher at 20.”
BackgroundInfluential
Symptom Burden in the First Year After Cancer Diagnosis: An Analysis of Patient-Reported Outcomes
Bubis, L. D., Davis, L., Mahar, A., Barbera, L., Li, Q., Moody, L., Karanicolas, P., Sutradhar, R., & Coburn, N. G. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.0876 · Cited by 187
Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer
Cocks, K., Wells, J. R., Johnson, C. A., Schmidt, H., Koller, M. T., Oerlemans, S., Velikova, G., Pinto, M., Tomaszewski, K. A., Aaronson, N. K., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.10.026 · Cited by 195
The Lancet Breast Cancer Commission
Coles, C. E., Earl, H. M., Anderson, B. O., Barrios, C. H., Bienz, M., Bliss, J. M., Cameron, D., Cardoso, F., Cui, W., Francis, P. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00747-5 · Cited by 209
Equitably improving outcomes for cancer survivors and supporting caregivers: A blueprint for care delivery, research, education, and policy
Alfano, C. M., Leach, C. R., Smith, T. G., Miller, K. D., Alcaraz, K. I., Cannady, R. S., Wender, R. C., & Brawley, O. W. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21548 · Cited by 179
Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment
Mack, J. W., McFatrich, M., Withycombe, J. S., Maurer, S. H., Jacobs, S. S., Lin, L., Lucas, N. R., Baker, J. N., Mann, C. M., Sung, L., et al. (2020) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2020.2861 · Cited by 196
“Radiotherapy 18 (9) 11 (8) 4 (3) 33 (7)”
A systematic review of randomised controlled trials evaluating the use of patient-reported outcome measures (PROMs)
Ishaque, S., Karnon, J. D., Chen, G., Nair, R., & Salter, A. B. (2018) · Quality of Life Research · doi:10.1007/s11136-018-2016-z · Cited by 187
The Future of Wearable Technologies and Remote Monitoring in Health Care
Liao, Y., Thompson, C. A., Peterson, S. K., Mandrola, J. M., & Beg, M. S. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238919 · Cited by 195
“…that in-clinic and/or remote monitoring of symptoms during chemotherapy, when coupled with support by care providers upon worsening of symptoms, resulted in better quality of life, fewer treatment interruptions, and improved survival in cancer patients with or without metastatic disease 12–14 .”
Background
The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer
Maguire, R., Fox, P. A., McCann, L., Miaskowski, C. A., Kotronoulas, G., Miller, M., Furlong, E., Ream, E., Armes, J., Patiraki, E. I., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015016 · Cited by 172
Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
Scotté, F., Bossi, P., Carola, É., Cudennec, T., Dielenseger, P., Gomes, F., Knox, S., & Strasser, F. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy228 · Cited by 174
The Value and Future Developments of Multidisciplinary Team Cancer Care
Selby, P. J., Popescu, R. A., Lawler, M., Butcher, H., & Costa, A. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_236857 · Cited by 176
Mitigating acute chemotherapy-associated adverse events in patients with cancer
Kuderer, N. M., Desai, A. P., Lustberg, M. B., & Lyman, G. H. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00685-3 · Cited by 179
Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care
Thomas, M. B., Jones, P. G., Arnold, S. V., & Spertus, J. A. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2020.7478 · Cited by 166
Benefits of mobile apps in pain management: Systematic review
Thurnheer, S. E., Gravestock, I., Pichierri, G., Steurer, J., & Burgstaller, J. M. (2018) · JMIR mHealth and uHealth · doi:10.2196/11231 · Cited by 160
“Basch et al [41] demonstrated that access to a Web-based collection of information about symptoms at home during chemotherapy with alerts to treating staff is beneficial for patients.”
Background
Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis
Efficace, F., Collins, P. G. S., Cottone, F., Giesinger, J. M., Sommer, K., Anota, A., Schlüssel, M. M., Fazi, P., & Vignetti, M. (2021) · Value in Health · doi:10.1016/j.jval.2020.10.017 · Cited by 156
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial
Mir, O., Ferrua, M., Fourcade, A., Mathivon, D., Duflot-Boukobza, A., Dumont, S., Baudin, É., Delaloge, S., Malka, D., Albiges, L. K., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01788-1 · Cited by 153
Clinical Integration of Digital Solutions in Health Care: An Overview of the Current Landscape of Digital Technologies in Cancer Care
Garg, S., Williams, N. L., Ip, A., & Dicker, A. P. (2018) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00159 · Cited by 154
Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review
van Egdom, L. S. E., Oemrawsingh, A., Verweij, L. M., Lingsma, H. F., Koppert, L. B., Verhoef, C. K., Klazinga, N., & Hazelzet, J. A. (2019) · Value in Health · doi:10.1016/j.jval.2019.04.1927 · Cited by 151
Effect of Collaborative Telerehabilitation on Functional Impairment and Pain Among Patients With Advanced-Stage Cancer: A Randomized Clinical Trial
Cheville, A. L., Moynihan, T., Herrin, J., Loprinzi, C., & Kroenke, K. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0011 · Cited by 143
Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer
Lizee, T., Basch, E., Tremolieres, P., Voog, É., Dômont, J., Peyraga, G., Urban, T., Bennouna, J., Septans, A.-L., Balavoine, M., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.02.005 · Cited by 142
Self-citation
Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis
Hughes, S., Haroon, S., Subramanian, A., McMullan, C., Aiyegbusi, O. L., Turner, G. M., Jackson, L., Davies, E. H., Frost, C., McNamara, G., et al. (2022) · BMJ · doi:10.1136/bmj-2022-070230 · Cited by 144
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
Rugo, H. S., O’Shaughnessy, J., Boyle, F. M., Toi, M., Broom, R. J., Blancas, I., Gümüş, M., Yamashita, T., Im, Y.-H., Rastogi, P., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.03.006 · Cited by 142
Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review
Aiyegbusi, O. L., Kyte, D. G., Cockwell, P., Marshall, T. P., Gheorghe, A., Keeley, T., Slade, A. L., & Calvert, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179733 · Cited by 139
Innovations in research and clinical care using patient‐generated health data
Jim, H., Hoogland, A. I., Brownstein, N. C., Barata, A., Dicker, A. P., Knoop, H., Gonzalez, B. D., Perkins, R. M., Rollison, D. E. M., Gilbert, S. M., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21608 · Cited by 149
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
Thanarajasingam, G., Minasian, L. M., Baron, F., Cavalli, F., de Claro, R. A., Dueck, A. C., El‐Galaly, T. C., Everest, N., Geißler, J., Gisselbrecht, C., et al. (2018) · The Lancet Haematology · doi:10.1016/s2352-3026(18)30051-6 · Cited by 140
Self-citation
Mobile health technology: a novel tool in chronic disease management
Fan, K., & Zhao, Y. (2021) · Intelligent Medicine · doi:10.1016/j.imed.2021.06.003 · Cited by 150
Patient-Reported Outcomes for Breast Cancer
Tevis, S. E. A., James, T. A., Kuerer, H. M., Pusic, A. L., Yao, K. A., Merlino, J. I., & Dietz, J. R. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6616-1 · Cited by 136
Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial
Lu, Z., Fang, Y., Liu, C. X., Zhang, X., Xin, X., He, Y., Cao, Y., Jiao, X., Sun, T., Pang, Y. K., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01254 · Cited by 136
“Previous studies have demonstrated the benefits of supportive care in terms of QoL, symptom control, and mood management.(16,18) In 2017, Basch et al(19) identified the survival benefits of supportive care based on patient-reported outcomes, which highlighted the importance of early symptom control for preventing wors…”
Background
Best Practices for Reducing Unplanned Acute Care for Patients With Cancer
Handley, N. R., Schuchter, L. M., & Bekelman, J. E. (2018) · Journal of Oncology Practice · doi:10.1200/jop.17.00081 · Cited by 137
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Mehrotra, R., Davison, S. N., Farrington, K., Flythe, J. E., Foo, M., Madero, M., Morton, R. L., Tsukamoto, Y., Unruh, M. L., Cheung, M., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.05.019 · Cited by 135
“41 44 Current PROMs are insuf ﬁ cient for determining symptom impact on the patient ’ s life, and they do not necessarily identify all priority concerns.”
Background
Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review
Bouazza, Y. B., Chiairi, I., Kharbouchi, O. E., Backer, L. D., Vanhoutte, G., Janssens, A., & van Meerbeeck, J. P. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.09.011 · Cited by 134
An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer
Zerillo, J. A., Schouwenburg, M. G., van Bommel, A. C. M., Stowell, C. J., Lippa, J., Bauer, D., Berger, A. M., Boland, G., Borràs, J. M., Buss, M. K., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0417 · Cited by 142
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial
Fred Saad, C., Cella, D. F., Basch, E., Hadaschik, B. A., Mainwaring, P. N., Oudard, S. M., Graff, J. N., McQuarrie, K., Li, S., Hudgens, S. A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30456-x · Cited by 131
“…The scores for five FACT-P subscales (physical wellbeing [seven items], social and family wellbeing [seven items], emotional wellbeing [six items], functional wellbeing [seven items], and prostate cancer subscale [12 items]) can be added together to make a single overall score (appendix pp 36–41).”
BackgroundSelf-citation
Patients’ experiences and perspectives of patient-reported outcome measures in clinical care: A systematic review and qualitative meta-synthesis
Carfora, L., Foley, C. M., Hagi-Diakou, P., Lesty, P. J., Sandstrom, M. L., Ramsey, I., & Kumar, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267030 · Cited by 131
Addressing the needs of cancer survivors during the COVID-19 pandemic.
Nekhlyudov, L., Duijts, S., Hudson, S. V., Jones, J. M., Keogh, J., Love, B., Lustberg, M., Smith, K. C., Tevaarwerk, A., Yu, X., et al. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00884-w · Cited by 130
Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement
Sullivan, D. R., Iyer, A. S., Enguidanos, S. M., Cox, C. E., Farquhar, M. C., Janssen, D. J. A., Lindell, K. O., Mularski, R. A., Smallwood, N., Turnbull, A. E., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202207-1262st · Cited by 134
Patient-Reported Outcome Measures in Cancer Care
Balitsky, A. K., Rayner, D. G., Britto, J., Lionel, A. C., Ginsberg, L., Cho, W., Wilfred, A. M., Sardar, H., Cantor, N., Mian, H. S., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.24793 · Cited by 134
The use of patient-reported outcome measures to improve patient-related outcomes – a systematic review
Bonsel, J. M., Itiola, A. J., Huberts, A. S., Bonsel, G. J., & Penton, H. (2024) · Health and Quality of Life Outcomes · doi:10.1186/s12955-024-02312-4 · Cited by 141
Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments
Dupuis, L. L., Johnston, D. L., Baggott, C., Hyslop, S., Tomlinson, D., Gibson, P. J., Orsey, A. D., Dix, D. B., Price, V., Vanan, M., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx250 · Cited by 127
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management
Solassol, I., Pinguet, F., & Quantin, X. (2019) · Biomolecules · doi:10.3390/biom9110668 · Cited by 129
“A randomized trial showed that patients receiving chemotherapy for advanced cancer, web-based symptom reporting with automated clinician e-mail alerts resulted in better health-related quality of life, fewer emergency room visits, fewer hospitalizations, and superior quality-adjusted survival [120].”
Background
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group
Henneghan, A. M., Dyk, K. V., Kaufmann, T. L., Harrison, R. A., Sidey-Gibbons, C. J., Heijnen, C. J., & Kesler, S. R. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab027 · Cited by 122
“with patient-centered care, and it can improve cancer patients’ quality of life (90).”
Background
Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment
Holch, P., Warrington, L., Bamforth, L., Keding, A., Ziegler, L. E., Absolom, K. L., Hector, C., Harley, C., Johnson, O. A., Hall, G. D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx317 · Cited by 121
“The immediate severityrelated guidance on how to manage AE is a unique feature of our system compared to other ePRO web-portals [11-13,16].”
Background
Relevance of randomised controlled trials in oncology
Tannock, I. F., Amir, E., Booth, C. M., Niraula, S., Ocaña, A., Šeruga, B., Templeton, A. J., & Vera-Badillo, F. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30572-1 · Cited by 121
A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice
Pawloski, P. A., Brooks, G. A., Nielsen, M. E., & Olson‐Bullis, B. A. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.7104 · Cited by 119
Building Personalized Cancer Follow-up Care Pathways in the United States: Lessons Learned From Implementation in England, Northern Ireland, and Australia
Alfano, C. M., Jefford, M., Maher, J., Birken, S. A., & Mayer, D. K. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238267 · Cited by 124
From guidelines to clinical practice: a roadmap for oncologists for nutrition therapy for cancer patients
Muscaritoli, M., Arends, J., & Aapro, M. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919880084 · Cited by 140
Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer – A randomized controlled trial
Fjell, M., Langius‐Eklöf, A., Nilsson, M. I., Wengström, Y., & Sundberg, K. K. (2020) · The Breast · doi:10.1016/j.breast.2020.03.004 · Cited by 120
The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: results of a population-based retrospective matched cohort analysis
Barbera, L., Sutradhar, R., Seow, H., Mittmann, N., Howell, D., Earle, C. C., Li, Q., & Thiruchelvam, D. (2020) · Cancer Medicine · doi:10.1002/cam4.3374 · Cited by 111
Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: A Multicenter Randomized Controlled Trial
Dai, W., Feng, W., Zhang, Y., Wang, X. S., Liu, Y., Pompili, C., Xu, W., Xie, S.-H., Wang, Y., Liao, J. X., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01344 · Cited by 120
“First, PRObased symptom management proactively prompts clinicians to intervene early, before symptoms worsen and complications develop.(6) Second, PRO-based symptom management can be administered remotely and in real time.”
Background
Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis
Bunevičienė, I., Mekary, R. A., Smith, T. R., Onnela, J.-P. “., & Bunevičius, A. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103123 · Cited by 117
“Nevertheless, our findings support that mHealth interventions can help improve the HRQoL of cancer patients or prevent it from deteriorating, a phenomenon that is often inevitable given the progressive course of the disease (Basch et al., 2016; Bunevicius et al., 2020; Giesinger et al., 2011).”
Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literature
Anatchkova, M., Donelson, S. M., Skalicky, A. M., McHorney, C. A., Jagun, D., & Whiteley, J. (2018) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-018-0091-0 · Cited by 111
Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study
Crafoord, M.-T., Fjell, M., Sundberg, K. K., Nilsson, M. I., & Langius‐Eklöf, A. (2020) · Journal of Medical Internet Research · doi:10.2196/17058 · Cited by 114
“Most have been web-based and have involved symptom assessments from a home computer or clinic tablet [4,6,33,35].”
Background

Authors: Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D.
Affiliations: University of North Carolina at Chapel Hill (US)
Ethan Basch, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch, Allison M. Deal, and Antonia V. Bennett, University of North Carolina, Chapel Hill, NC; Amylou C. Dueck, Mayo Clinic, Scottsdale, AZ; Allison Barz, Children’s Hospital of Philadelphia, Philadelphia, PA; Paul Novotny and Jeff A. Sloan, Mayo Clinic,...
ORCID: Basch, Ethan
Deal, Allison M.
Kris, Mark G.
Scher, Howard I.
Hudis, Clifford A.
Sabbatini, Paul
Rogak, Lauren
Bennett, Antonia V.
Dueck, Amylou C.
Atkinson, Thomas M.
Chou, Joanne F.
Dulko, Dorothy
Sit, Laura
Novotny, Paul
Fruscione, Michael
Sloan, Jeff A.
Schrag, Deborah
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2016-02-20
Volume: 34
Issue: 6
Pages: 557-565
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2015.63.0830
PMC: PMC4872028
OpenAlex: W2195040438
Cited by: 2,593
References: 36
Citations by year: 2026: 252 · 2025: 263 · 2024: 321 · 2023: 288 · 2022: 316 · 2021: 299 · 2020: 292 · 2019: 191 · 2018: 180 · 2017: 143 · 2016: 44
FWCI: 53.87
Type: journal article
Language: en
Update notices: correction (2019-02-07)
correction (2016-06-20)
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Clinical Oncology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Memorial Sloan-Kettering Cancer Center
Society of Memorial Sloan Kettering
National Cancer Institute (P30CA008748, P30CA015083, P30CA016086)
Topics: Health Sciences › Medicine › Oncology › Cancer survivorship and care
Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords: patient-reported outcomes, symptom monitoring, cancer chemotherapy, health-related quality of life, advanced solid tumors, e-mail alerts, emergency department visits, hospitalization, survival, quality-adjusted survival, computer literacy, outpatient oncology
MeSH terms: Adult, Aged, Aged, 80 and over, Ambulatory Care, Antineoplastic Agents, Emergency Service, Hospital, Female, Hospitalization, Humans, Male, Middle Aged, Neoplasms, Quality of Life, Survival Rate, Internet, Nurse's Role, Electronic Mail, Self Report, Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks